BridgeMD
New treatment option for Pain
Official title Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management
ClinicalTrials.gov ID: NCT06804434
What this study is testing
What is Lidocaine Intravenous Infusion?
Lidocaine Intravenous Infusion is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This prospective randomised clinical trial aims to assess the impact of intraoperative nociception monitoring using NOL on anesthetic management during major abdominal surgery. Additionally, the study will objectively evaluate using NOL how intravenous lidocaine administration, influences opioid requirements and the effect of this multimodal approach on early postoperative outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- age \> 18 years
- ASA score I-III
- surgery for gastric or hepatobiliary or pancreatic neoplasia
You likely can't join if
- pregnancy
- lactation
- neuraxial or regional anesthesia
- chronic treatment with drugs that can influence autonomic nervous system
- diuretics or nitroglycerin administration on the day of surgery
- severe neurological disability
See the full eligibility criteria
- age \> 18 years
- ASA score I-III
- surgery for gastric or hepatobiliary or pancreatic neoplasia
- pregnancy
- lactation
- neuraxial or regional anesthesia
- chronic treatment with drugs that can influence autonomic nervous system
- diuretics or nitroglycerin administration on the day of surgery
- severe neurological disability
- severe hemodynamic instability
- chronic pain
- chronic opioid treatment
- allergy to any of the study drugs
- severe untreated disease or organ failure
- pacemaker
- emergency surgery
- patient refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Cluj-Napoca, Cluj, Romania
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cluj-Napoca, Cluj, Romania. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.